Pasadena, Canada-based oral care company Swiftsure Innovations closed its seed funding at CAD 2.3 million. The round took place on May 22, 2023. Pelorus VC led the financing for the company. Meanwhile, Sandpiper Ventures and pan-Canadian consortium MEDTEQ+ and several other pre-seed investors joined in the round.

Purpose of financing for Swiftsure Innovations 

With the latest capital injection, Swiftsure Innovations seeks to begin the commercialization of its offerings. 

It also has plans to deploy funds towards bacterial reduction research. 

What the company’s Chief Executive Officer has to comment

Deanne McCarthy, CEO and founder at Swiftsure said, “This funding provides us with capital to commercialize SwishKit, our innovative oral care solution for intubated patients. It also funds our bacterial reduction study that follows our successful first-use clinical trial.”

What the investors and experts have to add

The Honourable Andrew Parsons, KC, Minister of Industry, Energy and Technology, further said, “Powering high-growth firms through venture capital support is key to building on the significant momentum propelling our local tech industry. Congrats to Deanne and her team at Swiftsure as they take the next steps towards commercialization. We are proud to play a continued role in their journey.”

In addition, Sarah Murphy, Partner at Pelorus VC, said, “We are delighted to continue to support Swiftsure and their mission to improve ventilated patient outcomes. The team has strategically used past funding to make rapid progress towards commercialization and clinical proof of concept. As an ICU nurse, Deanne has considerable real-life experience with the problem Swiftsure is addressing, and it shows in how quickly this team has moved from ideation to commercially ready. We’re excited to back them once again and look forward to seeing the impact they make with this next round of funding.”

Besides, Rhiannon Davies, Co-founder and Managing Partner, Sandpiper Ventures, said, “The Swiftsure team is making great progress with their technology, and we are very pleased to play a lead role in this funding round. Deanne has done a tremendous job growing a global network and delivering exciting results through recent clinical trials. We look forward to what’s ahead for the company.”

About the company 

Deanne McCarthy in 2020 launched the company. Swiftsure develops and commercializes novel medical devices focused on providing innovative oral care solutions for critically ill patients. The company is on a mission to provide a better-quality life and outcomes for mechanically ventilated patients. 

For more extensive analysis and Market Intelligence reports, feel free to approach us.

We try our best to fact-check and bring well-researched as well as non-plagiarized content to you. Please let us know

if there are any discrepancies in any of our published stories,

-how we can improve,

-what stories you would like us to cover

–what information you are looking for in the comments section below or through our contact form! We look forward to your feedback, and thank you for stopping by!

Next Article

Previous articleUSA-based FlowX.AI raises USD 35 million in Series A
Next articleAdvanced AI-based startup Axelera AI raises USD 50 million in Series A funding
Jasleen Bhatia works as a content writer for VCBay News. She is pursuing her final semester in Bachelor of Business Administration from IIPS, DAVV. Driven by her keen interest in entrepreneurship and finance, she writes business-related articles.


Please enter your comment!
Please enter your name here